Vaxcyte, Inc. - COMMON STOCK (PCVX)

CUSIP: 92243G108

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
131,352,709
Total 13F shares
56,496,728
Share change
+5,045,011
Total reported value
$1,356,264,990
Put/Call ratio
98%
Price per share
$24.00
Number of holders
121
Value change
+$122,059,625
Number of buys
72
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q3 2022

As of 30 Sep 2022, Vaxcyte, Inc. - COMMON STOCK (PCVX) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,496,728 shares. The largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Abingworth LLP, BlackRock Inc., TPG GP A, LLC, STATE STREET CORP, Medicxi Ventures Management (Jersey) Ltd, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 121 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.